神经内分泌肿瘤是一组异质性肿瘤,核医学在诊断工作和靶向治疗方案中起着重要作用。本指南旨在协助核医学医师推荐,表演,使用68Ga-DOTA缀合肽报告和解释生长抑素受体(SSTR)PET/CT成像的结果,以及各种神经内分泌肿瘤的18F-DOPA成像。
EANM先前关于使用具有68Ga缀合的肽的PET/CT肿瘤成像的程序指南已被修订和更新,并有杰出专家的贡献。
Neuroendocrine neoplasms are a heterogenous group of tumours, for which nuclear medicine plays an important role in the diagnostic work-up as well as in the targeted therapeutic options. This
guideline is aimed to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of somatostatin receptor (SSTR) PET/CT imaging using 68Ga-DOTA-conjugated peptides, as well as 18F-DOPA imaging for various neuroendocrine neoplasms.
The previous procedural
guideline by EANM regarding the use PET/CT tumour imaging with 68Ga-conjugated peptides has been revised and updated with the relevant and recent literature in the field with contribution of distinguished experts.